Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Califf Nomination Adds New Dynamic, Maybe New Provisions, To FDA Reform Bills

Executive Summary

Senate legislation may be influenced by movement to push through Califf’s nomination for FDA commissioner.


Related Content

Califf Nomination May Show Confidence In His Bipartisan Appeal
PDUFA Budgeting: What Will Get Added, Subtracted – Or Multiplied By Cures?
Senator Tells FDA To Create ‘Red Team’ For Regulatory Streamlining
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus
Life After White Oak: Hamburg’s Predecessors Offer Glimpse At Where Pharma Might See Her Again
FDA Succession Planning Targeted In House Legislation


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts